Article Versions Notes

Friedl N, Krieger T, Chevreul K, Hazo JB, Holtzmann J, Hoogendoorn M, Kleiboer A, Mathiasen K, Urech A, Riper H, et al. Using the Personalized Advantage Index for Individual Treatment Allocation to Blended Treatment or Treatment as Usual for Depression in Secondary Care. Journal of Clinical Medicine. 2020; 9(2):490. https://doi.org/10.3390/jcm9020490

Friedl, Nadine, Tobias Krieger, Karine Chevreul, Jean Baptiste Hazo, Jérôme Holtzmann, Mark Hoogendoorn, Annet Kleiboer, Kim Mathiasen, Antoine Urech, Heleen Riper, and et al. 2020. "Using the Personalized Advantage Index for Individual Treatment Allocation to Blended Treatment or Treatment as Usual for Depression in Secondary Care" Journal of Clinical Medicine 9, no. 2: 490. https://doi.org/10.3390/jcm9020490

Friedl, N., Krieger, T., Chevreul, K., Hazo, J. B., Holtzmann, J., Hoogendoorn, M., Kleiboer, A., Mathiasen, K., Urech, A., Riper, H., & Berger, T. (2020). Using the Personalized Advantage Index for Individual Treatment Allocation to Blended Treatment or Treatment as Usual for Depression in Secondary Care. Journal of Clinical Medicine, 9(2), 490. https://doi.org/10.3390/jcm9020490